研究業績

学会発表

Long-term outcomes of eribulin‑based neoadjuvant chemotherapy for triple‑negative breast cancer: results of the randomized JBCRG-22 study


Hiroyuki Yasojima, Norikazu Masuda, Hiroko Bando, Takashi Yamanaka, Hideo Shigematsu, Masato Takahashi, Shigenori E. Nagai, Mitsuya Ito, Tomoyuki Aruga, Mariko Tokiwa, Shigeru Imoto, Rikiya Nakamura, Hiroshi Ishiguro, Hidetaka Kawabata, Shigehira Saji, Hironori Haga, Satoshi Morita, Masakazu Toi


ESMO Breast, 2025 May, Berlin Germany(Poster)

BRCA Genetic Testing Implementation and the Impact of BRCA Pathogenic Variant Status on Clinical Outcomes in HER2-Negative Metastatic and Recurrent Breast Cancer in Japan


Ayaka Sakakibara, Masahiro Ohara, Hiroshi Ishiguro, Naoki Niikura, Yasuaki Sagara, Shigehira Saji, Norikazu Masuda, Akihiko Osaki


ESMO Breast , 2025 May, Berlin Germany(Poster)

Patient-reported fatigue and general pain and the impact on health-related quality of life (HRQoL) in Japanese patients with advanced breast cancer (ABC) treated with palbociclib (PAL) + endocrine therapy (ET): analysis from 6-month observational study (JBCRG-26)


Hiroko Bando, Mari Oba, Aya Ueda, Kaori Terata, Mihoko Doi, Shigenori Nagai, Masaya Hattori, Kenichi Watanabe, Nobuko Tamura, Manabu Futamura, Kei Koizumi, Naoki Niikura, Tempei Miyaji, Yasuaki Muramatsu, Linghua Xu, Asuka Matsui, Norikazu Masuda, Shigehira Saji


ESMO Breast , 2025 May, Berlin Germany(Poster)

Toward personalization of HER2-targeted therapy


Takayuki Ueno, Hiu Ting Chan, Hiroji Iwata, Yutaka Yamamoto


Global Breast Cancer Conference, 2025 Apr, Korea(Poster)

Fertility preservation and assisted reproductive technologies in breast cancer patients interrupting adjuvant endocrine therapy to attempt pregnancy


Hatem A Azim Jr, Samuel M Niman, Ann H Partridge, Isabelle Demeestere, Monica Ruggeri, Marco Colleoni, Cristina Saura, Chikako Shimizu, Anna B Saetersdal, Judith R Kroep, Audrey Mailliez, Ellen Warner, Virginia F Borges, Frédéric Amant, Andrea Gombos, Akemi Kataoka, Christine Rousset-Jablonski, Simona Borstnar, Junko Takei, Jeong E Lee, Janice M Walshe, Manuel Ruíz-Borrego, Halle C F Moore, Christobel Saunders, Vesna Bjelic-Radisic, Snezana Susnjar, Fatima Cardoso, Natalie J Klar, Tanja Spanic, Kathryn Ruddy, Martine Piccart, Larissa A Korde, Aron Goldhirsch †, Richard D Gelber, Olivia Pagani, Fedro A Peccatori


San Antonio Breast Cancer Symposium, 2024 Dec, Texas, USA (Oral)

Does postmastectomy radiotherapy in ‘intermediate-risk’ breast cancer impact overall survival? 10 year results of the BIG 2-04 MRC randomized trial on behalf of the SUPREMO trial investigators


Ian Kunkler


San Antonio Breast Cancer Symposium, 2024 Dec, Texas, USA (Oral)

進行・再発乳癌患者・家族の支援に対する看護職の困難感の実態(TEPPICH-ABC)


Chie Watanabe, Chikako Shimizu, Naomi Sakurai, Yoshiaki Kamei, Yuichiro Kikawa, Shigehira Saji, Yuko Takeishi, Yoshie Hasegawa, Megumi Matsumoto, Norikazu Masuda


第62回日本癌治療学会学術集会, 2024 Oct, Fukuoka, Japan (Oral)

Treatment satisfaction in patients with HR+/HER2- advanced breast cancer in Japan treated with palbociclib+endocrine therapy (ET) or ET alone: 6-month longitudinal study (JBCRG-26)


Mihoko Doi, Hiroko Bando, Mari S. Oba, Aya Ueda, Kaori Terata, Shigenori Nagai, Masaya Hattori, Kenichi Watanabe, Nobuko Tamura, Naoki Niikura, Tempei Miyaji, Asuka Matsui, Linghua Xu, Norikazu Masuda, Shigehira Saji


第62回日本癌治療学会学術集会, 2024 Oct, Fukuoka, Japan (Oral)

Examining the association between patient-reported outcomes and physical activity metricsin patients with HR+/HER2 advanced breast cancer treated with palbociclib plus endocrine therapy or endocrine therapy alone


Mari S. Oba, Tempei Miyaji, Hiroko Bando, Aya Ueda, Kaori Terata, Mihoko Doi, Shigenori Nagai, Masaya Hattori, Kenichi Watanabe, Nobuko Tamura, Manabu Futamura, Kei Koizumi, Naoki Niikura, Yasuaki Muramatsu, Linghua Xu, Asuka Matsui, Norikazu Masuda, Shigehira Saji


The International Society for Quality of Life Research (ISOQOL) Annual Conference, 2024 Oct, Cologne, Germany (Oral)

Biomarkers for Palbociclib in Fulvestrant-Resistant Metastatic Breast Cancer Using cfDNA Cancer Panel Sequencing


Takashi Takeshita, Takayuki Iwamoto, Naoki Niikura, Kenichi Watanabe, Yuichiro Kikawa, Kokoro Kobayashi, Nobutaka Iwakuma, Takuho Okamura, Hiroshi Tada, Shinji Ozaki, Toshitaka Okuno, Uhi Toh, Yutaka Yamamoto, Michiko Tsuneizumi, Hiroshi Ishiguro, Norikazu Masuda, Shigehira Saji


第83回日本癌学会学術総会, 2024 Sep, Fukuoka, Japan (AACRアンコール、Oral)

前のページへ 次のページへ
任意団体JBCRG 研究業績